J L Monstastruc < J L Montastruc < J L Renard

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 60.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000011 (1999)	J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin	A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000036 (1999)	O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc	Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000047 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
000064 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
000127 (2000)	O. Rascol [France] ; J L Montastruc	[Role of dopaminergic agonists].
000183 (2001)	O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc	The pharmacologic treatment of gait ignition failure.
000189 (????)	J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre	Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
000191 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000200 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000201 (2001)	J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L Montastruc	Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
000208 (2001)	O. Rascol [France] ; J J Ferreira ; C. Thalamas ; M. Galitsky ; J L Montastruc	Dopamine agonists. Their role in the management of Parkinson's disease.
000227 (2001)	O. Rascol [France] ; J. Ferreira ; J L Montastruc	[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
000315 (2003)	G. Fénelon [France] ; S. Giménez-Roldán ; J L Montastruc ; F. Bermejo ; F. Durif ; I. Bourdeix ; J-J Péré ; L. Galiano ; J. Schadrack	Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
000323 (2002)	O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc	[Management of levodopa-induced dyskinesia].
000422 (1992)	G. Durrieu [France] ; M E Llau ; O. Rascol ; J M Senard ; A. Rascol ; J L Montastruc	Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
000581 (1992)	J M Senard [France] ; B. Chamontin ; A. Rascol ; J L Montastruc	Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension.
000631 (????)	J L Montastruc [France]	Recent advances in the clinical pharmacology of Parkinson's disease.
000713 (1992)	O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J L Montastruc ; J P Marc-Vergnes ; A. Rascol	Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
000718 (1991)	J L Montastruc [France] ; O. Rascol ; J M Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol	Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
000921 (1991)	O. Rascol ; U. Sabatini ; M. Simonetta-Moreau ; J L Montastruc ; A. Rascol ; M. Clanet	Square wave jerks in parkinsonian syndromes.
000985 (1991)	U. Sabatini ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J P Marc-Vergnes ; J L Montastruc	Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "J L Montastruc" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "J L Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    J L Montastruc
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024